OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
22.06
-0.16 (-0.72%)
Sep 9, 2026, 11:10 AM EDT - Market open
OrthoPediatrics Revenue
OrthoPediatrics had revenue of $70.51M in the quarter ending June 30, 2026, with 15.43% growth. This brings the company's revenue in the last twelve months to $252.73M, up 14.49% year-over-year. In the year 2025, OrthoPediatrics had annual revenue of $236.35M with 15.45% growth.
Revenue (ttm)
$252.73M
Revenue Growth
+14.49%
P/S Ratio
2.30
Revenue / Employee
$419,807
Employees
602
Market Cap
575.98M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 236.35M | 31.62M | 15.45% |
| Dec 31, 2024 | 204.73M | 56.00M | 37.65% |
| Dec 31, 2023 | 148.73M | 26.44M | 21.62% |
| Dec 31, 2022 | 122.29M | 24.24M | 24.72% |
| Dec 31, 2021 | 98.05M | 26.97M | 37.95% |
| Dec 31, 2020 | 71.08M | -1.47M | -2.03% |
| Dec 31, 2019 | 72.55M | 14.99M | 26.05% |
| Dec 31, 2018 | 57.56M | 11.94M | 26.17% |
| Dec 31, 2017 | 45.62M | 8.32M | 22.31% |
| Dec 31, 2016 | 37.30M | 6.29M | 20.30% |
| Dec 31, 2015 | 31.00M | 7.32M | 30.91% |
| Dec 31, 2014 | 23.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 865.00M |
| Tactile Systems Technology | 350.31M |
| Cerus | 221.55M |
| Cytek Biosciences | 206.71M |
| NeuroPace | 106.99M |
| Delcath Systems | 95.42M |
| Sight Sciences | 83.38M |
| BrainsWay | 60.70M |
KIDS News
- 15 days ago - OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations - GlobeNewsWire
- 20 days ago - OrthoPediatrics price target raised to $29 from $24 at BTIG - TheFly
- 4 weeks ago - OrthoPediatrics Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - OrthoPediatrics price target raised to $22 from $20 at Truist - TheFly
- 5 weeks ago - OrthoPediatrics price target raised to $25 from $22 at Piper Sandler - TheFly
- 5 weeks ago - OrthoPediatrics price target raised to $28 from $25 at Canaccord - TheFly
- 5 weeks ago - OrthoPediatrics price target raised to $24 from $22 at Stifel - TheFly
- 5 weeks ago - OrthoPediatrics Earnings Call Transcript: Q2 2026 - Transcripts